Progression inference for somatic mutations in cancer

作者: Leif E. Peterson , Tatiana Kovyrshina

DOI: 10.1016/J.HELIYON.2017.E00277

关键词: Somatic cellKRASInferenceIDH1CancerGenePrecision medicineDownregulation and upregulationBiologyGenetics

摘要: Computational methods were employed to determine progression inference of genomic alterations in commonly occurring cancers. Using cross-sectional TCGA data, we computed …

参考文章(224)
Larissa J. Lee, Elena Ratner, Mohamed Uduman, Kathryn Winter, Marta Boeke, Kathryn M. Greven, Stephanie King, Thomas W. Burke, Kelly Underhill, Harold Kim, Raleigh J. Boulware, Herbert Yu, Vinita Parkash, Lingeng Lu, David Gaffney, Adam P. Dicker, Joanne Weidhaas, The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Trials 9708 and 9905 PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0094167
Karen L-A. Burr, Annemarie van Duyn-Goedhart, Peter Hickenbotham, Karen Monger, Paul P.W. van Buul, Yuri E. Dubrova, The effects of MSH2 deficiency on spontaneous and radiation-induced mutation rates in the mouse germline. Mutation Research. ,vol. 617, pp. 147- 151 ,(2007) , 10.1016/J.MRFMMM.2007.01.010
Magdalena Cizkova, Aurélie Susini, Sophie Vacher, Géraldine Cizeron-Clairac, Catherine Andrieu, Keltouma Driouch, Emmanuelle Fourme, Rosette Lidereau, Ivan Bièche, PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups Breast Cancer Research. ,vol. 14, pp. 1- 9 ,(2012) , 10.1186/BCR3113
Isabel M. Chu, Wei-Chu Lai, Olga Aprelikova, Lara H. El Touny, Hosein Kouros-Mehr, Jeffrey E. Green, Expression of GATA3 in MDA-MB-231 Triple-negative Breast Cancer Cells Induces a Growth Inhibitory Response to TGFß PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0061125
Camilla Krakstad, Even Birkeland, Danila Seidel, Kanthida Kusonmano, Kjell Petersen, Siv Mjøs, Erling A. Hoivik, Elisabeth Wik, Mari Kyllesø Halle, Anne M. Øyan, Karl-Henning Kalland, Henrica Maria Johanna Werner, Jone Trovik, Helga Salvesen, High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated PLOS ONE. ,vol. 7, ,(2012) , 10.1371/JOURNAL.PONE.0052795
Mary Coolbaugh-Murphy, Atousa Maleki, Lou Ramagli, Marsha Frazier, Benjamin Lichtiger, Darren G. Monckton, Michael J. Siciliano, Barry W. Brown, Estimating mutant microsatellite allele frequencies in somatic cells by small-pool PCR. Genomics. ,vol. 84, pp. 419- 430 ,(2004) , 10.1016/J.YGENO.2004.03.007
Ayesha Joshi, Christopher Miller, Suzanne J. Baker, Lora H. Ellenson, Activated mutant p110α causes endometrial carcinoma in the setting of biallelic Pten deletion. American Journal of Pathology. ,vol. 185, pp. 1104- 1113 ,(2015) , 10.1016/J.AJPATH.2014.12.019
E Birkeland, E Wik, S Mjøs, E A Hoivik, J Trovik, H M J Werner, K Kusonmano, K Petersen, M B Raeder, F Holst, A M Øyan, K-H Kalland, L A Akslen, R Simon, C Krakstad, H B Salvesen, KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. British Journal of Cancer. ,vol. 107, pp. 1997- 2004 ,(2012) , 10.1038/BJC.2012.477
IC Gray, LMD Stewart, SMA Phillips, JA Hamilton, NE Gray, GJ Watson, NK Spurr, D Snary, Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN British Journal of Cancer. ,vol. 78, pp. 1296- 1300 ,(1998) , 10.1038/BJC.1998.674
Moritz Gerstung, Nicholas Eriksson, Jimmy Lin, Bert Vogelstein, Niko Beerenwinkel, The temporal order of genetic and pathway alterations in tumorigenesis. PLOS ONE. ,vol. 6, ,(2011) , 10.1371/JOURNAL.PONE.0027136